FDA Inspection
PLZ Corp.PLZ Corp. – FDA Inspection, Jun 7, 2019
Record Details
This FDA Inspection record concerns PLZ Corp., with an inspection on June 7, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Yumi J. Hiramine (Issuing Officer)
View Company Profile
ID · 87fc7138-69d7-4a43-9260-7aa5b3520e94
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1092200
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.68(b)input/output verification
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of PLZ Corp.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| September 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for PLZ Corp.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.